Functional magnetic resonance imaging and antipsychotics. Overview and own data

被引:5
作者
Braus D.F. [1 ,2 ]
Brassen S. [1 ]
机构
[1] NeuroImage Nord, Psychiat. Zentrum F. P., Univ. Klin. Hamburg-Eppendorf
[2] NeuroImage Nord, Psychiat. Zentrum F. P., Univ. Klin. Hamburg-Eppendorf, 20246 Hamburg
来源
Der Radiologe | 2005年 / 45卷 / 2期
关键词
Atypical antipsychotics; Brain function; fMRI; Functional magnetic resonance imaging;
D O I
10.1007/s00117-004-1156-z
中图分类号
学科分类号
摘要
Recently, there has been growing interest in using functional magnetic resonance imaging (fMRI) for the evaluation of psychopharmacological drugs. fMRI studies in healthy human volunteers and psychiatric patients focus on cerebral activity following acute drug administration (single challenge) and on adaptive effects on neural networks due to long-term medication. In our own fMRI studies, the effects of olanzapine or amisulpride in never treated or medication-free schizophrenic patients using robust motor, visual, and acoustic tasks were longitudinally examined. In agreement with previous reports in the literature it could be shown that, in contrast to traditional neuroleptics, atypical drugs do not decrease the activation of the sensorimotor cortex but rather normalize the reduced frontoparietal activation as well as the neuropsychological test results. This encourages the assumption that atypical antipsychotics seem to support the recovery or normalization of frontoparietal brain dysfunction in schizophrenia. However, with these new opportunities additional methodological considerations and limitations emerge. © Springer Medizin Verlag 2004.
引用
收藏
页码:178 / 185
页数:7
相关论文
共 34 条
[1]  
Andreasen N.C., Nopoulos P., O'Leary D.S., Miller D.D., Wassink T., Flaum M., Defining the phenotype of schizophrenia: Cognitive dysmetria and its neural mechanisms, Biol Psychiatry, 46, pp. 908-920, (1999)
[2]  
Bartlett E.J., Brodie J.D., Simkowitz P., Et al., Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects, Am J Psychiatry, 151, pp. 681-686, (1994)
[3]  
Bertolino A., Blasi G., Caforio G., Latorre V., DeCandia M., Rubino V., Callicott J.H., Mattay V.S., Bellomo A., Scarabino T., Weinberger D.R., Nardini M., Functional lateralization of the sensorimotor cortex in patients with schizophrenia: Effects of treatment with olanzapine, Biol Psychiatry, 56, pp. 190-197, (2004)
[4]  
Bertolino A., Caforio G., Blasi G., De Candia M., Latorre V., Petruzzella V., Altamura M., Nappi G., Papa S., Callicott J.H., Mattay V.S., Bellomo A., Scarabino T., Weinberger D.R., Nardini M., Interaction of COMT Val108/158 Met genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia, Am J Psychiatry, 161, pp. 1798-1805, (2004)
[5]  
Brassen S., Tost H., Hoehn F., Weber-Fahr W., Klein S., Braus D.F., Haloperidol challenge in healthy male humans: A functional magnetic resonance imaging study, Neurosci Lett, 340, pp. 193-196, (2003)
[6]  
Braus D.F., Krier A., Sartorius A., Ende G., Hubrich-Ungureanu P., Henn F.A., Effects of haloperidol and lorazepam on fMRI data in healthy subjects. Third International Conference on Functional Mapping of the Human Brain, NeuroImage, 5, (1997)
[7]  
Braus D.F., Ende G., Weber-Fahr W., Sartorius A., Krier A., Hubrich-Ungureanu P., Ruf M., Stuck S., Henn F.A., Antipsychotic drug effects on motor activation measured by functional magnetic resonance imaging in schizophrenic patients, Schizophr Res, 39, pp. 19-29, (1999)
[8]  
Braus D.F., Ende G., Tost H., Weber-Fahr W., Jatzko A., Schmitt A., Demirakca T., Ruf M., Funktionelle Kernspintomographie und Schizophrenie: Medikamenteneffekte, methodische Grenzen und Perspektiven, Nervenheilkunde, 3, pp. 121-128, (2000)
[9]  
Braus D.F., Ende G., Weber-Fahr W., Demirakca T., Tost H., Henn F.A., Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia, Eur Neuropsychopharmacol, 12, pp. 145-152, (2002)
[10]  
Braus D.F., Weber-Fahr W., Tost H., Ruf M., Henn F.A., Sensory information processing in neuroleptic-naive first-episode schizophrenic patients: A functional magnetic resonance imaging study, Arch Gen Psychiatry, 59, pp. 696-701, (2002)